Evidence for population-based BRCA1 and BRCA2 screening for ovarian cancer prevention

被引：0
|
作者：
Levy-Lahad, E. [1 ]
Gabai-Kapara, E. [1 ]
Kaufman, B. [2 ]
Catane, R. [2 ]
Segev, S. [3 ]
Renbaum, P.
Beller, U. [4 ]
King, M. C. [5 ,6 ]
Lahad, A. [7 ]
机构：
[1] Hebrew Univ Jerusalem, Sch Med, Inst Med Genet, Shaare Zedek Med Ctr, IL-91010 Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Div Oncol, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Inst Med Screening, IL-52621 Tel Hashomer, Israel
[4] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
[5] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA
[6] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[7] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [31] BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark
    Soegaard, Marie
    Kjaer, Susanne Kruger
    Cox, Mark
    Wozniak, Eva
    Hogdall, Estrid
    Hogdall, Claus
    Blaakaer, Jan
    Jacobs, Ian J.
    Gayther, Simon A.
    Ramus, Susan J.
    CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3761 - 3767
  • [32] Screening for BRCA1 and BRCA2 mutations in eastern Finnish breast/ovarian cancer families
    Hartikainen, J. M.
    Kataja, V.
    Pirskanen, M.
    Arffman, A.
    Ristonmaa, U.
    Vahteristo, P.
    Ryynanen, M.
    Heinonen, S.
    Kosma, V-M
    Mannermaa, A.
    CLINICAL GENETICS, 2007, 72 (04) : 311 - 320
  • [33] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
  • [34] OVARIAN CANCER SCREENING BY AUSTRALIAN WOMEN FROM FAMILIES WITH BRCA1 OR BRCA2 MUTATIONS
    Wuttke, M.
    Milne, R.
    Weideman, P.
    Picken, S.
    Smith, C.
    Friedlander, M.
    McLachlan, S.
    Hopper, J. L.
    Phillips, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 223 - 224
  • [35] Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Hyman, David M.
    Spriggs, David R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 408 - 410
  • [36] Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women
    Loizzi, Vera
    Cerbone, Marco
    Arezzo, Francesca
    Silvestris, Erica
    Damiani, Gianluca Raffaello
    Cazzato, Gerardo
    Cicinelli, Ettore
    Cormio, Gennaro
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (02): : 277 - 286
  • [37] Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    Ramus, Susan J.
    Harrington, Patricia A.
    Pye, Carole
    DiCioccio, Richard A.
    Cox, Mark J.
    Garlinghouse-Jones, Kim
    Oakley-Girvan, Ingrid
    Jacobs, Ian J.
    Hardy, Richard M.
    Whittemore, Alice S.
    Ponder, Bruce A. J.
    Piver, M. Steven
    Pharoah, Paul D. P.
    Gayther, Simon A.
    HUMAN MUTATION, 2007, 28 (12) : 1207 - 1215
  • [38] Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
    Pietragalla, Antonella
    Arcieri, Martina
    Marchetti, Claudia
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1803 - 1810
  • [39] Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
    British Journal of Cancer, 2000, 83 : 1301 - 1308
  • [40] Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
    Ponder, BAJ
    Day, NE
    Easton, DF
    Pharoah, PDP
    Lipscombe, JM
    Redman, K
    Antoniou, A
    Basham, V
    Gregory, J
    Gayther, S
    Dunning, A
    BRITISH JOURNAL OF CANCER, 2000, 83 (10) : 1301 - 1308
12345